The Edinburgh Experimental Cancer Medicine Centre brings together scientific and clinical research, sharing knowledge and resources for the benefit of cancer patients. The centre facilitates the translational research needed to develop new anti-cancer drugs, support discovery and validation of new diagnostic, prognostic and predictive markers and drug-target discovery.
The ECMC has developed a robust infrastructure to support research and development of novel cancer treatments and interventions in human participants aiming to deliver patient benefit in the short to medium term. As part of these endeavours ECMC has set up and developed a cancer biospecimens resource, governance and quality systems to ensure best practice, research protocols and standard operating procedures to cover all aspects of tissue biobanking and an E-health infrastructure comprising a sample management system linked to clinical databases. The ECMC also provides generic support for focused, mechanistic clinical trials, enabling translational research from the laboratory to the clinic.
Through these endeavours the Experimental Cancer Medicine Centre provides infrastructure for the research and development of novel cancer treatments and interventions in human participants aiming to deliver patient benefit in the short to medium term.